Roopal V Kundu

Grants

Grants per year 2004 2004 2008 2010 2012 2017 2018 2019 2021 2022 2024 2027

• 1 Active
• 13 Finished

Grants per year

Search results

• Finished

  Understanding Skin of Color and Improving Outcomes in Patients of Color

  Kundu, R. V. (PD/PI), Paller, A. (Other), Rangel, S. M. (Other) & Riley, J. M. (Other)

  Pfizer Inc.

  7/1/22 → 6/30/23

  Project: Research project

• Prot#INCB 18424-308 "A Double-Blind, Vehicle-Controlled, Randomized Withdrawal and Treatment Extension Study to Assess the Long-Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo"

  Kundu, R. V. (PD/PI)

  Premier Research International, LLC, Incyte Corporation

  7/21/21 → 7/21/24

  Project: Research project

• Prot #CTP009: A Prospective Blinded Within-Subject Randomized Controlled Clinical Study to Investigate the Safety and Effectiveness of RECELL® for Repigmentation of Stable Vitiligo Lesions

  Kundu, R. V. (PD/PI)

  AVITA Medical Americas, LLC

  5/13/21 → 5/13/24

  Project: Research project

• Prot #INCB 18424-306: A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream Followed by an Extension Period in Participants With Vitiligo

  Kundu, R. V. (PD/PI)

  Premier Research International, LLC, Incyte Corporation

  8/5/19 → 6/1/23

  Project: Research project

• Prot #MRG201-30-201: A Phase 2, Double-blind, Placebo-Controlled Study to Investigate the Efficacy, Safety and Tolerability of MRG-201 Following Intradermal Injection in Subjects with a History of Keloids

  Kundu, R. V. (PD/PI)

  Novella Clinical, LLC, miRagen Therapeutics, Inc.

  6/26/18 → 6/26/21

  Project: Research project

• Prot #RVK 09062016: Gene Expression and Biomarker Profiling of Keloid Skin

  Kundu, R. V. (PD/PI)

  Regeneron Pharmaceuticals, Inc.

  6/28/17 → 8/31/22

  Project: Research project

• Prot #INCB 18424-211: A Randomized, Double-Blind, Dose-Ranging Study of INCB018424 Phosphate Cream in Subjects With Vitiligo

  Kundu, R. V. (PD/PI)

  Premier Research International, LLC, Incyte Corporation

  6/16/17 → 8/31/22

  Project: Research project

• Effectiveness of a knowledge-based intervention on quality of life for patients with cutaneous lupus erythematosus

  Kundu, R. V. (PD/PI)

  Arnold P. Gold Foundation

  4/27/12 → 9/27/12

  Project: Research project

• Development and Validation of a Health-Related Quality of Life Instrument for Vitiligo

  Kundu, R. V. (PD/PI) & West, D. P. (Co-Investigator)

  Skin of Color Society

  2/1/10 → 1/31/13

  Project: Research project

• Assessment and Development of Educational Tools for the Detection of Signs of Melanoma within Minority Patients

  Kundu, R. V. (PD/PI)

  Arnold P. Gold Foundation

  5/15/08 → 10/15/08

  Project: Research project

• Assessment and Development of Educational Tools for the Detection of Signs of Melanoma within Minority Patients

  Kundu, R. V. (PD/PI)

  Arnold P. Gold Foundation

  5/15/08 → 10/15/08

  Project: Research project

• Prot# 03-4OHT-01: A Randomized, Double-Blind, Placebo Controlled Trial of 4-Hydroxy Tamoxifen Gel in Women with Symptomatic Keloid Scars

  Kundu, R. V. (PD/PI) & West, D. P. (Co-PD/PI)

  ASCEND Therapeutics, Inc., Besins International U.S. Inc.

  11/8/04 → 7/31/07

  Project: Research project

• Prot# 03-4OHT-01: A Randomized, Double-Blind, Placebo Controlled Trial of 4-Hydroxy Tamoxifen Gel in Women with Symptomatic Keloid Scars

  Kundu, R. V. (PD/PI) & West, D. P. (Co-PD/PI)

  ASCEND Therapeutics, Inc., Besins International U.S. Inc.

  11/8/04 → 7/31/07

  Project: Research project